Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 25.35
+0.10 (0.40%)
At close: Feb 11, 2026
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.54 billion as of February 11, 2026. Its market cap has decreased by -15.92% in one year.
Market Cap
1.54B
Enterprise Value
1.19B
Revenue
355.40M
Ranking
n/a
PE Ratio
852.80
Stock Price
25.35
Market Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.54B, a decrease of -47.24%. That is a compound annual growth rate of -3.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.53B | 11.23% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 1.98B |
| Advagene Biopharma | 1.90B |
| Genomics BioSci & Tech. | 1.80B |
| NeoCore Technology | 1.54B |
| GenMont Biotech Incorporation | 1.54B |
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.32B |